@Value2WealthIND Solix Empower 2026:
Oct 28th - Oct 30th 2026
The Agentic Enterprise: Reimagining Enterprise applications with Enterprise AI
Sponsership & Partnerships:
Wipro
Cognizant
Tech Mahindra
UC San diego
empower.solix.com
English
S_r_i
146 posts
TechNVision's live Solix Empower 2025 can be watch at
youtu.be/4s0ZjKLPDDA . It will start at 9:30 PM IST .
YouTube
Value2Wealth Investor@Value2WealthIND
This time TechNVision's #SolixEmpower 2025 looks to be biggest in it's history . Lot of TechNVision's customers , leadership team ,partners and peers are attending it (More than 50 speakers) . We can get lot of more insight about their products and use cases. empower.solix.com/2025-san-diego/ 1. Aditya Gadiko — Senior Director of AI Product Management at Emmes Group 2. Alex Woodie — Managing Editor of HPCwire 3. Archaana Pattabhii — Senior Vice President at Citibank 4. Barry Rudolph — VP & GM at IBM (ret) 5. Benjamin Smarr — Associate Professor at UC San Diego 6. Brendan Daly — Chief Information Security Officer; Deputy Director, IT Architecture and Engineering at City of San Diego 7. Bryon Rickey — Director of Enterprise Data Governance and Privacy at ASP 8. Carl Gerber — Consultant & Former CDO at Deloitte, KPMG 9. Prof. David Danks — Professor of Data Science, Philosophy & Policy at UC San Diego 10. Dr. Deb Barnes — Consultant and Former CDO at USAA Banking 11. Erik Mjoen — Director of Industry Relations at The School of Computing, Information and Data Science at UC San Diego 12. Prof. Frank Wuerthwein — Director at the San Diego Supercomputer Center 13. Govil Kumar — Director of Business Analytics & Planning at Honeywell 14. Greg Horowitt — Director of Innovation at UC San Diego 15. Ian Brazil — Assistant Deputy Director of Compliance and Digital Equity at City of San Diego 16. Dr. James C.S. Meng — Deputy Assistant Secretary of the Navy (ret), Senior Fellow, UC San Diego 17. James Massa — Senior Executive Director of Software Engineering and Architecture at JPMorgan Chase 18. Dr. James Short — Lead Scientist and Director, SPARK AI Consortium, UC San Diego 19. Jamie Cho — Head of Software at Sapient 20. Jim Lee — VP, Data Services at Solix Technologies, Inc. 21. Dr. Joe Lancaster — VP Enterprise AI, Solix Technologies, Inc. 22. John Ottman — Executive Chairman at Solix Technologies, Inc. 23. Jonathan Behnke — CIO at the City of San Diego 24. Prof. Kiana Aran — Associate Professor of Bioengineering at UC San Diego Jacobs School of Engineering 25. Kishore Gadiraju — CTO at Solix Technologies, Inc. 26. Dr. Krishnaiah Kurapati — Chief Executive Officer at Basavatarakam Indo American Cancer Hospital & Research Institute 27. Dr. Krishnamohan Yarlagadda — Director at Virinchi People’s Hospitals 28. Lily Weng — Assistant Professor at the School of Computing, Information and Data Sciences at UC San Diego 29. Maj Dean Mirmirani — Dean at Embry-Riddle Aeronautical University (Ret) 30. Mark Lee — Senior Vice President, Services at Solix Technologies, Inc. 31. Mervyn (Merv) Lally — CIO at HealthEquity, Inc. 32. Mohit Jain — MD, PhD, Founder & CSO at Sapient 33. Murali Krishnam — VP Product Management at Solix Technologies, Inc. 34. Dr. Nabil Adam — Professor Emeritus at Rutgers University and Co-founder & CEO at Phalcon, LLC 35. Paul Maher — General Manager at Microsoft 36. Pedro Pagan — Director of IT at Whitecap 37. Phyllis Saavedra — VP Finance Transformation at Emagia 38. Pramod Gollahalli — Product Manager and Pre-Sales Solutions Engineer at Solix Technologies, Inc. 39. Praveen Beedanagari — Sr. Enterprise Data Architect at NetApp 40. Dr. Rafiq Dossani — Director at The Rand Corporation 41. Prof. Rajesh Gupta — Dean, School of Computing, Information and Data Sciences at UC San Diego 42. Dr. Raju Puspati — VP Life Sciences at Solix Technologies, Inc. 43. Robin Perry Mayrand — Senior Data Scientist at Johnson & Johnson 44. Sai Gundavelli — Founder & CEO at Solix Technologies, Inc. 45. Santo Campione — Director of IT at McDonald’s 46. Sharat Shravanam — Solix CDP SME | Pre-Sales Solution Engineer at Solix Technologies, Inc. 47. Steve Tallant — Director of Product Marketing at Solix Technologies, Inc. 48. Steven Meltzer — Partner at Pillsbury Winthrop Shaw Pittman LLP 49. Suresh Mani — Chief AI Architect at Solix Technologies, Inc. 50. Syed Qadri — Director, Data Management and Analytics at Western Financial Group 51. Tao Long — Co-Founder and Head of Data Sciences at Sapient 52. Timothy (K.) Mackey — Professor at UC San Diego Global Health Program 53. Valquir Correa — VP of Corporate Finance at Baha Mar 54. Veena Gundavelli — Founder & CEO at Emagia 55. Vikram Kumar — CEO at MultiplierAI 56. Vrajesh Bhavsar — CEO & Co-Founder at Operant AI
English
@Value2WealthIND Observation: Interestingly Suresh Mani is now involved in many panelist discussions recently. Solix Spreading the word here among varied audiences. Small steps go a long way sometimes as they say.
English
@Value2WealthIND Solix mentioned in Comparison with Informatica, IBM infosphere, Opentext, Microsoft Purview in the data lifecycle management space in the AI Journal. Worth a read 📖
aijourn.com/data-lifecycle…
English
TechNVision ( Solix Technologies) and founder CEO Sai Gundavelli got Data Transformation Excellence Award 2026 by "The Silicon Review"
Congratulations to team Solix .
thesiliconreview.com/magazine/profi…
thesiliconreview.com/magazine/profi…
English
@Value2WealthIND NSE listing just the start in Solix's space i feel. Why?👇
1. SAP aquired Reltio (Making master data AI ready)
2. Open AI aquired Torch (Patient health record management)
3. Anthropic aquired coefficient Bio (Uses AI to boost efficiency in drug discovery and biological research)
English
@market_timer Yes , they never cared about stock price thats why I surprised.
English
TechNVision listing to NSE is still mystery to me .
NSE listing get initiated by company and The company submits a formal application to the NSE under the "New Listing" and there is compliance overhead. TechNVision don't share even simple investor presentation why they would do all these efforts.
I suspect it is requested by some big name . Block deal on the card .
What is your view ? @Arunstockguru @market_timer @growth_picker or anyone want to chip in
English
@Value2WealthIND Adding to the above, again why Quantum + AI is a game changer in pharma is highlighted in the below post. Solix pivot looks a solid path forward.
linkedin.com/pulse/why-90-d…
English
Following is recent linkedin post from Sai GundaVelli of Solix Technologies ( TechNVision) on stepping into #Pharma AI Drug Discovery .
<
Stepping into Pharma Journey and Why ?
As many of you know, Solix Technologies, Inc. has long been recognized for Enterprise Data Management—helping organizations optimize storage, compute, and governance at scale.
So yes, stepping into #Pharma with Solix EAI Pharma seemed like a big leap. It was. But it’s also was an opportunity we couldn’t ignore.
#Drugdiscovery is one of the most complex, expensive, and time-consuming challenges in the world. The convergence of #data, #AI, and #quantumscience is creating a moment where meaningful acceleration is finally possible—and we believe we can play a significant role.
Here’s how we’re bringing it all together:
Solix EAI Pharma at the core, combines quantum-level simulation, AI-driven prediction, and intelligent automation into a unified drug discovery engine. Goes beyond pattern recognition → models real molecular behavior. Integrates semantic content libraries and molecular/protein datasets. Built with enterprise-grade security, governance, and #datasovereignty. Enables scalable, trustworthy discovery at speed
Why Quantum + AI matters - Traditional AI learns from historical patterns. Quantum-based approaches simulate the physics of molecules—electrons, bonds, and reactions.
The result - Better decisions earlier → fewer late-stage failures → lower cost and faster timelines
Solix CDP (Cloud Data Platform) - An infinitely scalable platform to unify:
- Historical data (including failed experiments)
- Active research pipelines
- Legacy discoveries
In Pharma, failed pursuits are often ignored. We see them as critical learning signals to train better AI models and enable a “fail fast, learn faster” approach.
Solix EDG (Enterprise Data Governance) - End-to-end governance for data and AI—ensuring trust, compliance, and responsible innovation.
Solix ECS (Enterprise Content Services)Supports clinical and regulatory ecosystems:
- eTMF (trial master files)
- EDC (clinical data capture)
Trial operations and complianceAll while addressing global data sovereignty challenges.
Beyond technology — a broader mission of our goal is not just to accelerate drug discovery, but to help reduce the cost of medicine and improve access globally. Through our CSR digital initiatives at Touch-A-Life Foundation.
#TALHospitals - Global Virtual Hospital
#TALMedora - Social platform connecting Doctors, Hospitals, Patients, Pharmaceuticals and Wellness care.
We are also exploring pathways to connect innovation with real-world #impact—including enabling early access ecosystems for clinical research and trials.
When you combine data, AI, quantum science, governance, and purpose-driven platforms, the opportunity is significant.
We’re just getting started. If you’re exploring the future of Pharma, AI, or drug discovery—let’s connect.
<>
Source : linkedin.com/posts/saigunda…
English
@Value2WealthIND @Gautam__Baid @NeerajCNBC Absolutely loved the video. Points related to sectors that can be the leaders of new bull run, indicators of bear/bull market along with its stages are precise. The idea to keep level headed, focus on health and enjoy process of investment is the way to go.
English
If you want to master the art of the 'cash call' and sector rotation, timing market by identifying phases of market cycle , this interview of @Gautam__Baid with @NeerajCNBC is a must-watch. It’s essentially a bible , but need to create your own strategy around this. I managed to nail the 2018 cycle with 40% cash, but I was caught a bit off guard this time with only 12%. This video is a great resource for anyone looking to refine their strategy and avoid the pitfalls of the next cycle. Still learning every day.
youtu.be/WVO_lJijUP8
YouTube
English
@Value2WealthIND Sai Gundavelli Featured in the 2026 data transformation excellence award
thesiliconreview.com/magazine/profi…
English
@Value2WealthIND A message from Sai gundavelli. Note the last line "This is just the beginning" or again hinting to us and saying this is just the tip of the iceberg, as we are ending FY25-26. For now stock is definitely moving like an iceberg taking out retailers, could be powerplay 🔜 🤞😉
English
Last Line of David Zuccolotto is very important " I’ve never been more confident in where we’re headed. Solix has the industry's leading AI technology for Enterprise governance. Solix has the vision. And Solix has one of the strongest teams in the industry.
2026 will be unprecedented! "
S_r_i@market_timer
@Value2WealthIND The post below reiterates confidence of a breakthrough 2026 for Solix with their solid portfolio of products. Kudos to the entire team 👏. Train leaving platform soon. Catch it if you can 😉. linkedin.com/posts/davidzuc…
English
@manoj_aggi @Value2WealthIND Solix is creating a niche of its own in the data reporposing products through their exemplary AI governance frameworks. Big fishes Databricks , Snowflake and informatica definitely now should be feeling Solix's presence increasingly.
English
@market_timer @Value2WealthIND Almost all AI product need solix platform for effective working specially relyed to data
English
Solix Technologies ( TechNVision) , VirtualZ Partner to Expand Enterprise Data Access, AI Readiness
ittech-pulse.com/news/solix-vir…
English
@Vikas_stk Hmm it just says esm stage 1, 100 unique PAN, T2T thats all. Flat graph last 1 month with 171.3 upper circuit.
English
Some companies will be
easily 10x from here in
next 3-5 years.
Name some of them.🤔
#sharemarket
English
@Value2WealthIND TAL hospitals have launched a live webinar product where in engagement with real patients would become possible. A good step forward. Link to the youtube recording of one of first webinars below.
youtu.be/N6SYs79Ubaw?si…
YouTube
English
@Value2WealthIND Solix though Touch a life foundation will soon be coming up Heathcare data exchange marketplace. Sai gundavelli again spot on to spot the trends/tailwinds in healthcare. HIMS to AI led healthcare transformation play here on the cards involving Hospitals & Pharma.
English
Raju Pusapati is heading Life Science division at Solix Technologies (TechNVision) as VP .
His Linkedin profile is very impressive. You will rarely see this type of profile in small non pharma/Chem company.
linkedin.com/in/raju-pusapa…
He is PhD and scientist .
Earlier worked with
Exelixis as senior scientist (100000 cr market cap)
Aragen Life Sciences as Director (10000 cr valuation)
Bamboo tree seeds of AI Life Science division has been planted in Solix . It may take some time become bamboo tree from baby bamboo but defiantly will become one day.
We get these type of optionality/serendipity when we invest for long term in the company of quality technocrat promoters.
English
@Vikas_stk Why covance price is not at all moving everyday although shares are getting traded? Even i see the upper circuit limit does not change at all.
English
@Gaurav_7887 Covance Softsol
Pace Digitek
Goodluck India
OBSC Perfection
TechNVision
Unimech Aero
IZMO
Jeena Sikho
Čeština
@Value2WealthIND A discussion by Raju Pusapati on AI and its impact on pharmaceutical drug discovery
youtu.be/9bth0vsnXE4?si…
YouTube
English
Dr Raju Pusapati is heading Life Sciences division at Solix Technologies ( TechNVision)
He helps bridge gap between science and technology in his current role at Solix . So , I would include AI Drug discovery platform as MEDTECH.
Dr. Raju Pusapati is a biologist and drug discovery scientist with a distinguished 15+ year career spanning top-tier institutions like Genentech (Swiss pharmaceutical giant Roche Subsidiary) , Exelixis, and emerging biotech ventures.
He is trained at Harvard and Genentech/Roche .
Very impressive profile . Give him some time , we will get some good traction for Solix AI Drug discovery platform.
Vikas@Vikas_stk
@soicfinance , @suru27 and @Value2WealthIND Can AI drug discovery & development platform included in MEDTECH ? Only one player from India . TechNVision through silicon valley based subsidiary Solix . More than 10 Phd scientists in their team for AI drug discovery & development platform development .They built silently using existing data platform . Now , showing potential to world by participating in AI drug discovery & development summit Boston. Due to budget constraint ( fragile nature of management ) they are just bronze partner and Dr Raju Pusapati (linkedin.com/in/raju-pusapa…) VP, Life Sciences at Solix Technologies is speaker at event . aidrivendrugdevelopment.com/events/ai-driv…
English
@growth_picker Hope equisense spreads the potential the stock has. Still 5x potential atleast exists i feel, although huge alpha already made by few lucky long term retail investors in this counter. Again execution is the key.
English
@Value2WealthIND @Prophetdeprofit @Arunstockguru @manoj_aggi @InvestorAyush @EquityValueIn @ankitbahuguna84 1141 to 1112 story of strong hold continues. Arun bhai's accumulation continues. Some profit booking by big 5 but again getting redistributed overall.
English
@Value2WealthIND @Prophetdeprofit @Arunstockguru @manoj_aggi @InvestorAyush @EquityValueIn @ankitbahuguna84 1326 to 1141😁. Extreme concentration. Great SHP😃
English
TECHNVISION AGM updates
anyone please ?
thank you.
@Value2WealthIND @manoj_aggi @InvestorAyush @Arunstockguru @EquityValueIn @ankitbahuguna84
English
@Value2WealthIND I am not sure why this is not coming out as an official announcement? Its such a positive news.
English
Oh , that is really good news .I was not aware of it . Thanks for sharing.
Arun Mukherjee@Arunstockguru
@Value2WealthIND From today it started trading in NSE too. Quite a good news.
English
@Value2WealthIND From today it started trading in NSE too. Quite a good news.
English
TechNVision leadership team depth is one of the best in AI industry for this size, a rare confluence of vision , execution, and AI expertise with deep AI and platform DNA .It is enhanced more by this team .
Arun Mukherjee@Arunstockguru
English
@Value2WealthIND 🚨 Another Partnership alert 🚨
Now Solix customers have VirtualZ No-code patented real time software access, to any data sitting anywhere. Small steps though but definitely promising 👍
businesswire.com/news/home/2026…
English
Great NEWS : Solix Technologies(TechnVision) and Symbiosis Center for Entrepreneurship & Innovation going to Establish Centre of Excellence in New Drug Development and Drug Repurposing using Al-Powered Drug Discovery. Globally Al-Powered Drug Discovery going to be huge market and Solix is most prominent play from India .
Slowly even investors will understand TechnVision ( SOlix and Emgia) potential . Right now , not even 0.5% investors know anything about TechnVision/Solix .
The Center of Excellence aims to integrate:
1) Computational intelligence and Al-driven in-silico modeling
2) Molecular validation frameworks
3) In-vivo translational research
The initial focus areas will include:
1. Alzheimer’s disease
2. PAMR (Priority Antimicrobial Resistant) pathogens
This collaboration brings together Solix’s 25+ years of expertise in end-to-end data lifecycle management, governance, and Enterprise Al with SMCW’s clinical, translational, and biomedical research strengths
BSE announcement Link :
bseindia.com/xml-data/corpf…
I have earlier shared TechNVision quality talented management team analysis at if you have not seen earlier then check open.substack.com/pub/value2weal…
English